APA (7th ed.) Citation

Ortega-Paz, L., Laudani, C., Sionis, A., Vidal-Cales, P., Arevalos, V., Andrea, R., . . . Brugaletta, S. (2025). Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction—DAPA-STEMI Trial. Journal of cardiovascular development and disease, 12(6), 220. https://doi.org/10.3390/jcdd12060220

Chicago Style (17th ed.) Citation

Ortega-Paz, Luis, et al. "Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction—DAPA-STEMI Trial." Journal of Cardiovascular Development and Disease 12, no. 6 (2025): 220. https://doi.org/10.3390/jcdd12060220.

MLA (9th ed.) Citation

Ortega-Paz, Luis, et al. "Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction—DAPA-STEMI Trial." Journal of Cardiovascular Development and Disease, vol. 12, no. 6, 2025, p. 220, https://doi.org/10.3390/jcdd12060220.